任命新总裁 - Adtalem Global Education Inc. (NYSE: ATGE)任命Scott Liles为总裁，负责医学和兽医领域[1] - Scott Liles在全球组织领导和业务方面具有丰富经验，曾在ACAMS担任CEO和执行董事会成员[2] - Scott Liles拥有20多年领导使命驱动公司的经验，曾领导Nationwide Insurance的两家增长和创新公司[3] 学校表现优异 - Adtalem的医学学校和兽医学校表现优异，拥有98%的医学生第一次获得住院医生资格考试资格率和81%的兽医学生第一次通过NAVLE考试率[5]

Zacks Premium - Zacks Premium提供了多种方式帮助投资者更加聪明和自信地投资[1] Zacks Style Scores - Zacks Style Scores是一套独特的指导方针，根据价值、增长和动量特征对股票进行评级，帮助投资者选择未来30天内市场表现最佳的证券[3] VGM Score - VGM Score是所有Style Scores的综合指标，帮助筛选出具有最具吸引力价值、最佳增长预测和最有前景动量的公司[8]

Adtalem Global Education (ATGE) has been on a downward spiral lately with significant selling pressure. After declining 21.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting ...

CHICAGO--(BUSINESS WIRE)--Adtalem Global Education, Inc. (NYSE: ATGE) responds to claims in a report released on January 30 from Safkhet Capital. “The report contains numerous factual errors, demonstrates a poor understanding of our industry as well as rudimentary transaction accounting, and is a reckless attempt to defame the nation’s largest healthcare educator,” said Adtalem President and CEO Steve Beard. Safkhet Capital’s inability to accurately state even the most basic facts undermines the credibi ...

Second Quarter 2024 Earnings January 30, 2024 ©2024 Adtalem Global Education Inc. All rights reserved Safe FORWARD-LOOKING STATEMENTS ...

华尔街推荐股票 - 专业金融分析师指出，投资股票虽存在风险，但有必要关注华尔街推荐的股票[1] - 华尔街推荐的股票受到专业分析师的青睐，如微软（MSFT）和辉瑞（PFE）[2] - 微软（MSFT）被多位分析师看好，预期有潜在的股价上涨空间，而辉瑞（PFE）也被认为有长期投资机会[3]

公司业绩 - Adtalem Global Education Inc. (ATGE)在2024财年第二季度报告中，盈利和收入均超过了Zacks Consensus Estimate，并同比增长[1] - 调整后的每股收益为$1.23，超过了Zacks Consensus Estimate，同比增长51.4%[3] - 收入为$393.2百万美元，超过了预期，同比增长8.4%，主要受到Chamberlain University和Walden University需求强劲的推动[4] 公司展望 - 公司的增长战略表现出色，有机收入增长，运营效率提高，学术成果出色，因此ATGE提高了2024财年的指导预期[2]

Adtalem Global Education (ATGE) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 21.78%. A quarter ago, it was expected that this for-profit education company would post earnings of $0.82 per share when it actually produced earnings of $0.93, delivering a surprise of 13.41%.Over the la ...

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of Adtalem Global Education, Inc. dropped over 23% on January 30, 2024, after Safkhet Capital published a report alleging that the company’s business model uses deceptive tactics and pushes students into debt. Gibbs Law Group is investigating a potential Adtalem Securities Class Action Lawsuit on behalf of shareholders who lost money in Adtalem (NYSE: ATGE). What Should ATGE Investors Do? If you invested in Adtalem Global Education, visit our website by clicking ...

公司业绩 - Adtalem Global Education Inc. (NYSE: ATGE)报告了2024财年第二季度的业绩，显示加速增长的总入学人数和收入增长，强劲的盈利能力和高质量的学术成果[1] - 公司的收入为3.932亿美元，同比增长8.4%，运营收入为5,860万美元，调整后的运营收入为7,560万美元[3] - Adtalem将其2024财年的收入指导提高至15.2亿至15.6亿美元，调整后的每股收益范围为4.55至4.75美元[12] 学术项目 - Chamberlain University通过其在线护理学士学位（BSN）课程继续培养护士人才，该课程在32个州为学生提供灵活性和实践学习机会[4] - Walden University通过其Believe and Achieve™奖学金计划致力于推动工作专业人士的负担能力和可及性，奖励学生在取得学位进展方面的努力，有超过1.5万名学生参与[4] - Chamberlain的精神卫生护士执业者项目目前有2,200名学生，Walden的社会行为健康项目有18,000名学生，应对美国日益增长的与心理健康相关的挑战[4] 财务指标 - 专业金融分析师需要关注公司的非GAAP财务指标，其中包括特殊项目的描述，如重组费用、业务整合费用、无形资产摊销费用等[27][28] - 需要关注公司各部门的运营情况，比如Chamberlain部门的运营收入和利润情况，以及Home Office and Other部门的运营亏损情况[28][30] - 需要关注公司的调整后的EBITDA情况，包括Chamberlain和Walden部门的调整后EBITDA和调整后EBITDA利润率[45][46] - 公司的非GAAP净利润和调整后的每股收益情况也需要被关注，包括重组费用、业务整合费用、无形资产摊销费用等对净利润和每股收益的影响[72][76] - 公司的自由现金流和净杠杆率也是需要被关注的财务指标，可以帮助分析公司的财务状况和偿债能力[78][80]